In vitro cytotoxicity MTT assay in vero, HepG2 and MCF-7 cell lines study of marine yeast

Journal of Applied Pharmaceutical Science

Volumn 5, Issue 3, 2015, Pages 80-84

  Senthilraja, P ^a   Kathiresan, K ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Cancer; Cell culture; HepG2; MCF 7; MTT assay; Vero; Yeast

Indexed keywords

EID: 84926391795     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2015.50313     Document Type: Article

References (26)

1. Amador M.L., Jimeno J., Paz-Ares L., Cortes-Funes H. and Hidalgo M. 2003. Progress in the development and acquisition of anticancer agents from marine sources. Ann. Oncol., 14: 1607-1611.
2. Bradford M.M. "Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 1976;72: 248-254.
3. Bristow MR, Thompson PD, Martin RP, Mason JW, Billingham ME, Harrison DC. Early anthracycline cardiotoxicity. Am J Med 1978:65:823-832.
4. Diamond L., Kruszewski F., Aden D.P., Knowles B.B., and Baird W.M. Metabolic activation of benzo[a]pyrene by a human hepatoma cell line, Carcinogenesis. 1980;1:871-875.
5. Dillon DA, Guidi AJ, Schnitt SJ. Chapter 28: Pathology of Invasive Breast Cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition, Lippincott Williams & Wilkins, 2010.
6. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. X Gastroenterology, 2004; 126: 2:460-468.
7. Fotakis G., Timbrell J.A. In vitro cytotoxicity assays: comparison of LDH, neutral red. MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 2006; 160, 171-177.
8. Grever M.C.B. 2001. Cancer drug discovery and development. In: De Vita, V.H.S. and Rosenberg, S.A., (eds.) Cancer: Principles and practice of oncology. Philadelphia, Lippincott Raven, pp. 328-339.
9. Horiuchi N, Nakagava K, Sasaki Y, Minato K, Fujiwara Y, Nezu K, et al. In vitro antitumor activity of mitomycin C derivative (RM-49) and a new anticancer antibiotic (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay. Cancer Chemother Pharmacol 1988;22:246-50.
10. Katiyar RS, Singhvi NR, Kushwaha RV, Ramji Lal, Suryanarayana N. VA-mycorrhizal association in arjuna and jamun trees in forest of Bhandara region, Maharashtra, India. International Journal of Agricultural Sciences. 2009:4(1):229-232.
11. Knowles B.B., Howe C.C., and Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science, 1980; 209: 497-499.
12. Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y. Cardiovascular actions of berberine. Cardiovascular Drug Reviews.2001; 3:234-244.
13. Lazarus, D. Radiolarians decreased silicification as an evolutionary response to reduced Cenozoic ocean silica availability. Proc. Nat. Acad. Sci. USA, 2009; 106: 9333-9338.
14. Lazarus P., Blevins-Primeau A., Zheng Y., and Sun D. 2009. Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen. Ann. NY Acad. Sci. 1155: 99-111.
15. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Molecular Cancer Therapeutics. 2006a; 5: 296-308.
16. Marcsek Z.L, Zs. Kocsis, B. Szende, A. Tompa, Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells Cell Biology International, 2007: 31:1214-1219.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity tests. J. Immunol. Methods, 1983; 65, 55-63.
18. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2004. CA Cancer J Clin. 2005 55(2):74-108.
19. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death and Differentiation, 2003;10: 26-35.
20. Peters G.J., H.H. Backus, S. Freemantle, T.B. Van, P.G. Codacci, D.W. Van, C. Li, et al. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim. Biophys. Acta, 2002; 1587(2-3): 194-205.
21. Sassa S., O. Sugita, R.A. Galbraith, and A. Kappas. Drug metabolism by the human hepatoma cell HepG2. Biochem. Biophys. Res. Commun., 1987; 143: 52-57.
22. Scott Wadler M.D. Thalidomide for advanced hepatocellular carcinoma American Cancer Society. 2004;103:1;1-4.
23. Suffness, M. and J.M. Pezzuto, 1990. Assays related to cancer drug discovery. In: Hostettmann K (ed). Methods in Plant Biochemistry: Assays for Bioactivity, Vol. 6, Academic Press, London. 71-133.
24. Szende B, Tyihak E, Trezl L. Role of arginine and its methylated derivatives in cancer biology and treatment. Cancer Cell Int, 2001;17:1-3.
25. Szende B, Tyihak E, Trezl L. Role of arginine and its methylated derivatives in cancer biology and treatment. Cancer Cell Int 2001;17:1-3.
26. Tyihak E, Bocsi J, Timar F, Szende B. Formaldehyde promotes and inhibits the proliferation of cultured tumour and endothelial cells. Cell Prolif. 2001;34:135-41.